Stockreport

Nurix Therapeutics (NRIX): Revisiting Valuation After a 120% Three-Month Share Price Surge [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF See our latest analysis for Nurix Therapeutics. The recent surge looks like a reset in sentiment rather than a one off jump, with a 30 day share price return of 10.5% [Read more]